Free Access
Med Sci (Paris)
Volume 32, Number 11, Novembre 2016
Le microbiote : cet inconnu qui réside en nous
Page(s) 1023 - 1026
Section Nouvelles
Published online 23 December 2016
  1. Junquero D, Rival Y. Syndrome métabolique : quelle définition pour quel(s) traitement(s) ?. Med Sci (Paris) 2005 ; 21 : 1045–1053. [EDP Sciences] [PubMed] [Google Scholar]
  2. Marchesini G, Bugianesi E, Forlani G, et al. Nonalcoholic fatty liver, steatohepatitis, and the metabolic syndrome. Hepatology 2003 ; 37 : 917–923. [CrossRef] [PubMed] [Google Scholar]
  3. European Association for the Study of the Liver; European Organisation for Research and Treatment of Cancer. EASL-EORTC clinical practice guidelines: management of hepatocellular carcinoma. J Hepatol 2012 ; 56 : 908–943. [CrossRef] [PubMed] [Google Scholar]
  4. Hanahan D, Weinberg RA. Hallmarks of cancer: the next generation. Cell 2011 ; 144 : 646–674. [CrossRef] [PubMed] [Google Scholar]
  5. Jenne CN, Kubes P. Immune surveillance by the liver. Nat Immunol 2013 ; 14 : 996–1006. [CrossRef] [PubMed] [Google Scholar]
  6. Wolf MJ, Adili A, Piotrowitz K, et al. Metabolic activation of intrahepatic CD8+ T cells and NKT cells causes nonalcoholic steatohepatitis and liver cancer via cross-talk with hepatocytes. Cancer Cell 2014 ; 26 : 549–564. [CrossRef] [PubMed] [Google Scholar]
  7. Ma C, Kesarwala AH, Eggert T, et al. NAFLD causes selective CD4+ T lymphocyte loss and promotes hepatocarcinogenesis. Nature 2016 ; 531 : 253–257. [CrossRef] [PubMed] [Google Scholar]
  8. Shachaf CM, Kopelman AM, Arvanitis C, et al. MYC inactivation uncovers pluripotent differentiation and tumour dormancy in hepatocellular cancer. Nature 2004 ; 431 : 1112–1117. [CrossRef] [PubMed] [Google Scholar]
  9. Baeck C, Wehr A, Karlmark KR, et al. Pharmacological inhibition of the chemokine CCL2 (MCP-1) diminishes liver macrophage infiltration and steatohepatitis in chronic hepatic injury. Gut 2012 ; 61 : 416–426. [CrossRef] [PubMed] [Google Scholar]
  10. Henning JR, Graffeo CS, Rehman A, et al. Dendritic cells limit fibroinflammatory injury in nonalcoholic steatohepatitis in mice. Hepatology 2013 ; 58 : 589–602. [CrossRef] [PubMed] [Google Scholar]
  11. Xia S, Sha H, Yang L, et al. Gr-1+ CD11b+ myeloid-derived suppressor cells suppress inflammation and promote insulin sensitivity in obesity. J Biol Chem 2011 ; 286 : 23591–23599. [CrossRef] [PubMed] [Google Scholar]
  12. Kang TW, Yevsa T, Woller N, et al. Senescence surveillance of pre-malignant hepatocytes limits liver cancer development. Nature 2011 ; 479 : 547–551. [CrossRef] [PubMed] [Google Scholar]
  13. Rakhra K, Bachireddy P, Zabuawala T, et al. CD4+ T cells contribute to the remodeling of the microenvironment required for sustained tumor regression upon oncogene inactivation. Cancer Cell 2010 ; 18 : 485–498. [CrossRef] [PubMed] [Google Scholar]
  14. Faure-Dupuy S, Lucifora J. Régulation de l’immunopathogenèse du virus de l’hépatite B par des cellules myéloïdes suppressives. Med Sci (Paris) 2016 ; 32 : 290–296. [CrossRef] [EDP Sciences] [PubMed] [Google Scholar]

Current usage metrics show cumulative count of Article Views (full-text article views including HTML views, PDF and ePub downloads, according to the available data) and Abstracts Views on Vision4Press platform.

Data correspond to usage on the plateform after 2015. The current usage metrics is available 48-96 hours after online publication and is updated daily on week days.

Initial download of the metrics may take a while.